The sensitivity of mice to mouse hepatitis virus 3 (MHV3) infection varies according to strain, age, and immune status of the animals (5, 15) . Three types of sensitivity are observed: resistance, full susceptibility, and semisusceptibility. After MHV3 infection, semisusceptible mice develop a chronic disease characterized by the occurrence of paralysis and viral persistence, since MHV3 can be recovered from brain, liver, spleen, and lymph nodes in most animals during the first 3 months postinfection (16) . During the chronic phase of the disease, a progressive immunodeficiency occurs which is related to lympholysis and inhibition of antigendriven lymphocyte proliferation (17) . The marked involvement of the lymphoid system and the presence of MHV3 in lymphoid cells in infected animals (16) , as well as the capacity of the virus to replicate in vitro in lymphocytes (12) , led us to develop an in vitro model of MHV3 infection in lymphoblastoid cell lines.
We observed that MHV3 persistent infections can be carried out in vitro in permanent YAC and RDM-4 lymphoid cell lines and that MHV3 variants, derived from persistently infected YAC cells, lose their capacity to induce a lethal disease when injected into susceptible mice.
MATERIALS AND METHODS
Mice. A/J and C57BL/6 mouse strains were purchased from Jackson Laboratories, Bar Harbor, Maine. C57BL/6 * Corresponding author.
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newborns were bred in our mouse colony. Animal care and housing have already been reported (15) .
Cells. YAC and RDM-4 mouse lymphoid cell lines were obtained from S. Lemieux and D. 0th (Armand-Frappier Institute, Laval, Quebec, Canada). YAC cells (YAC-1 substrain) were derived from a Moloney virus-induced T-cell lymphoma of A/Sn origin and have been propagated as a suspension line in culture for several years (28) . RDM-4 cells originated from a B-cell lymphoma of AKR origin and were maintained by passages in vivo as well as in vitro (14) . Cells were grown in suspension culture in RPMI 1640 medium (Flow Laboratories, McLean, Va.) containing fetal calf serum at a concentration of 10% for YAC cells and 5% for RDM-4 cells, penicillin (100 U/ml), and streptomycin (100 mg/ml). Subcultures were performed by dilution with fresh culture medium when the cell density reached 5 x 105 cells per ml (YAC cells) and 106 cells per ml (RDM-4 cells). The doubling times of YAC and RDM-4 cells were 18 and 24 h, respectively. L2 cells, a continuous mouse fibroblast cell line (provided by R. Anderson, University of Western Ontario, London, Ontario, Canada) were grown in Eagle minimal essential medium with glutamine (2 mM), 5% fetal calf serum, and antibiotics. L2 cells were used for propagation, cloning, and titration of MHV3.
Peritoneal exudate cells were obtained after washings of the peritoneal cavity with 8 ml of RPMI 1640 medium containing 1% heparin (Allen & Hanbury, Toronto, Ontario, Canada). Peritoneal exudate cells were seeded in microtitration plates (5 x 105 cells per well) and cultured at 37°C under 5% CO2 for 3 days. 
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In all cultures, cell counts and viability were regularly determined. Cell viability was assessed by the trypan blue exclusion test (21) .
Cell cloning. Cloning of infected and uninfected cells was performed by the limit dilution assay (1 cell per 0.2 ml of medium) in 96-well microtitration plates. Plates were centrifuged at 500 x g for 10 min. All plates were checked daily, and the number of cells in each clone and the number of clones were recorded. When the number of cells per clone reached 300, cell clones were divided among three wells, and the plates were further incubated for 2 to 3 days until use.
Indirect immunofluorescence test. Sedimented cells of infected and uninfected control cultures were used for indirect immunofluorescence after the addition of 0.1 ml of Haygman medium (20 volumes Anti-MHV3 antibody. Anti-MHV3 antibody was raised in resistant A/J strain mice after two intraperitoneal injections of 1,000 50% lethal doses of virus given 2 weeks apart. Sera were collected 3 days after the last injection, pooled, titrated using the complement fixation test (4) .
In vivo pathogenicity assay. In vivo pathogenicity was determined by intraperitoneal injection of 0.1 ml of virus suspensions into susceptible C57BL/6 newborn and/or adult mice. Each group consisted of 5 to 10 mice, and the number of animals which survived during the first 2 weeks after injection was recorded.
Experimental design. In all experiments, studies were carried out in triplicate samples of MHV3-infected and uninfected cell cultures or cell clones. The three identical samples were used for (i) cell count and viability, (ii) indirect immunofluorescence, and (iii) determination of extracellular and cell-associated virus titers. RESULTS Establishment of MHV3 persistent infection. Persistent infections were established in YAC and RDM-4 cells and maintained for up to 100 days in some experiments. They were stopped at that time for convenience. In all cultures, the number of viable cells was regularly counted, and virus persistence was determined by virus production and detection of cellular viral antigens by immunofluorescence. Induction and maintenance of persistent MHV3 infections in YAC and RDM-4 cells were tested at various MOI (0.001 to 100). In YAC cells, a persistent infection occurred only at an MOI of ¢1, whereas all MOI induced viral persistence in RDM-4 cells. Figure 1 shows the results observed with 1 MOI. No difference in cell number was observed when infected and uninfected RDM-4 cells were compared. A marked difference, however, was observed in YAC cells (Fig. 1C) . In addition, a cell "crisis," characterized by a drastic decrease in cell number, occurred in infected cell populations at various times ( (Fig. 1A) . Large fluorescent syncytia were frequently seen during the first two passages postinfection, whereas small unfused fluorescent cells were observed thereafter. Infectious virus was produced by both persistently infected cell lines but reached a higher titer in RDM-4 cells. Titers varied with time, and no significant difference was seen between free virus and cell-associated virus titers (Fig. iB) .
To study the effect of fresh medium on the development of persistent infection, culture medium was changed every other day starting at the time of infection of YAC and RDM-4 cells with 1 MOI. In infected YAC cells, this procedure resulted in a marked increase in cell lysis, in the number of fluorescent cells, and in virus titers. No significant variations were observed in RDM-4 cells.
Cell cloning. Cell cloning of persistently infected and noninfected YAC and RDM-4 cells was performed by the limit dilution method. Cloning efficiency was estimated as the ratio of the number of growing clones to the number of expected clones. The cloning efficiency of infected (I) versus uninfected control (C) cells was expressed as an I/C ratio. In the first two experiments, the I/C ratios for YAC cells were 0.77 and 0.72. In experiment 3, a normal ratio of 1.01 was related to an abortive infection, since YAC cells had been inoculated with a low MOI (0.1). The percentages of fluorescent cells in experiments 2 and 3 were 20 and 0%, respectively. Virus did not persist in any of the clones tested, as evidenced by the absence of virus production (0 of 272), of immunofluorescent cells (0 of 160), and of resistance to superinfection (0 of 155). In two experiments performed with RDM-4 cells, the I/C ratios were 0.94 and 1.08. Similarly, neither production of virus (0 of 168) nor resistance to superinfection (0 of 101) was observed.
Effect of anti-MHV3 antibody. To evaluate the role of extracellular transmission of infection in virus persistence in YAC cells, anti-MHV3 antibody at a final concentration of 1:25 was added during four successive passages. The number of cells in infected cell populations progressively reached a level similar to that of uninfected populations, whereas the number of fluorescent cells progressively decreased (Fig. 2) . Free or cell-associated virus was not recovered after the first passage. Cell cultures were maintained during nine subsequent passages after extensive washings and culture in antibody-free medium. Infectious virus, cell-associated virus antigens, and resistance to superinfection were not observed, indicating virus disappearance.
Role of cellular metabolism. Table 1) .
The kinetics of heat inactivation of 10 isolates obtained from persistently infected YAC cells was compared with that of the parent virus. Parental MHV3 was completely inactivated at 45 and 50°C in 20 and 10 min, respectively. In addition, a 1.5 logl0 reduction of virus titer was obtained after 3 h of incubation at 37°C. Eight cloned viruses originating from persistently infected YAC cells exhibited a similar thermolability. When compared with the parent virus, however, one virus isolate appeared to be more thermolabile at 37 and 45°C, and another appeared to be more thermostable at 37°C.
In vivo pathogenicity. The capacity of YAC cell-derived MHV3 isolates to induce an acute disease upon injection into susceptible mice was tested using culture supernatants of YAC cells inoculated with parental MHV3 at an MOI of 1. At various times postinfection, in vitro virus titers and in vivo pathogenicity were determined. Although virus replication was regularly expressed in YAC cells during 45 days of culture with a yield between 104 and 107 TCID50/ml, the property of in vivo pathogenicity rapidly disappeared (Table  2) . Eight days after injection, YAC cell culture supernatants had lost their ability to induce an acute disease when injected into susceptible C57BL/6 mice. Since the disappearance of in vivo pathogenicity may be related to an accumulation of defective interfering particles (8), nonpathogenic (NP) MHV3 was diluted (10-1 to 10-6/ml), and in vivo pathogenicity was tested. No recovery of pathogenicity was obtained after NP virus dilutions.
In an attempt to determine whether in vivo injection of NP MHV3 could lead to virus elimination or to induction of a subclinical infection, liver and peritoneal macrophages of C57BL/6 mice injected with NP MHV3 were examined for the presence of virus. A persistent virus infection developed in C57BL/6 mice infected with NP MHV3, as evidenced by focus formation in peritoneal exudate cells and by the detection of low titers of virus in the liver (Fig. 4) . Subsequent experiments revealed that virus was recovered from peritoneal macrophages, liver, and brain in 3 of 45 animals from 4 to 6 months postinfection.
The in vivo pathogenicity of cloned MHV3 progeny derived from YAC or L2 cells was determined. Uncloned and cloned YAC-MHV3 were partially pathogenic for newborns but were not pathogenic for adult C57BL/6 mice, whereas full pathogenicity was observed with uncloned and cloned L2-MHV3 (Table 3 (15) 3 (20) 8 (25) 1 (9) 3 (10) 1 (9) 4 7 (17.5)
a Yield ratio was calculated as difference in virus titers obtained when cells were cultured at various temperatures for 18 h (37 to 39.50C) or 24 h (33 to 370C). (18, 26) . The mechanisms involved in such persistent infections are still unknown.
During persistent infections, different patterns of virus evolution have been described in which cytolytic virus infections are converted to more temperate host-virus interactions. Such variations could be related to production of defective interfering particles, antigenic drift, selection of mutants, or interaction with the interferon system (30) . Persistent infections induced in lymphoid human cell lines by measles or herpesvirus (3, 9) have been shown to promote the selection of thermosensitive mutants. We found that parental MHV3 produced virus populations that were heterogeneous with respect to thermosensitivity. Viral heterogeneity was maintained in persistently infected YAC cell cultures, and no selection of thermosensitive mutants appeared to be induced. Similar negative results were obtained with neuroblastoma cells persistently infected with JHM virus (26) . In addition, Lucas et al. (18) demonstrated that the rapid inhibition of MHV3 and JHM synthesis resulting from a shift to high temperature was not associated with the appearance of thermosensitive mutants but was related to a host factor.
Initiation and maintenance of persistent infections in cells capable of interferon production may be related to the development of defective interfering particles or virus mutants which stimulate an increased capacity of cells to produce interferon (25) . Neither interferon nor defective interfering particles were detected in MHV3 persistently infected YAC cell cultures. Similar negative results were obtained in persistent infections induced in vitro with other coronaviruses in animal (26) and human (2) cell lines.
Virus evolved from persistently infected lymphoid cell cultures can differ from the parent virus with respect to virulence markers such as in vivo pathogenicity. In persistent infections, the selective advantage of virus mutants of lower pathogenicity is apparent since it allows host survival (30) . MHV3 variants produced in persistently infected YAC cell cultures differed from the parent virus in their lack of pathogenicity when injected into susceptible mice. Similar results were observed in MHV3 persistent infection carried out in RDM-4 mouse lymphoid cells (data not shown). Thẽ These data indicate, therefore, that MHV3 replication in lymphoid cells leads to induction or selection of variants which maintain in vitro pathogenicity but display reduced in vivo pathogenic effects. Such variants seem to be responsible for the development of subclinical infection in susceptible adult mice. They display antigenic properties, as they can elicit defense mechanisms which enable infected animals to survive a challenge with virulent MHV3.
The ability of MHV3 to induce in vitro persistent infections in lymphoid cell lines suggests that a similar mechanism may be involved in vivo. Carrier-type transmission of infection may produce atrophy of lymphoid organs during the chronic phase of the disease and progressive immunodepression (17) . Conversely, high anti-MHV3 antibody titers should block transmission of infection and cure the animals. Persistent MHV3 infection in lymphoid cell lines represents an interesting model for studying virus-lymphocyte interactions as well as cellular mechanisms involved in the loss of pathogenicity. The in vivo significance, however, of the latter phenomenon has to be established, and its existence in normal lymphocytes would be an observation of major importance.
